This is the text extract for May 2009 Tender Results, browse documents here.

---

29 May 2009

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th June 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to listed pharmaceuticals where no other brand is listed – subsidy changes (where applicable) on 1 July 2009 and Sole Subsidised Supply commences on 1 October 2009.

The decisions were as follows:

Chemical Name Azithromycin Chloramphenicol Cyclizine hydrochloride Cyproterone acetate Ethinyloestradiol Felodipine Felodipine Lisinopril Lisinopril Lisinopril Mesalazine Methotrexate Methotrexate Methylprednisolone Methylprednisolone Norethisterone

Presentation; Pack size and type Tab 500 mg; 2 tablets OP, blister Eye oint 1%; 4 g OP, bottle Tab 50 mg; 10 tablets, blister Tab 50 mg; 50 tablets, blister Tab 10 mcg; 100 tablets, blister Tab long-acting 5 mg; 90 tablets, blister Tab long-acting 10 mg; 90 tablets, blister Tab 5 mg; 30 tablets, blister Tab 10 mg; 30 tablets, blister Tab 20 mg; 30 tablets, blister Enema 1 g per 100 ml; 7 enemas, bottle Tab 2.5 mg; 30 tablets, bottle Tab 10 mg; 50 tablets, bottle Tab 4 mg; 100 tablets, bottle Tab 100 mg; 20 tablets, bottle Tab 350 mcg; 84 tablets, blister

Current Subsidy $9.90 $2.48 $1.99 $23.50 $17.60 $16.50 $24.00 $2.78 $3.16 $3.91 $46.90 $5.80 $40.93 $48.57 $166.52 $7.15

New tender subsidy $5.95 $2.37 $1.59 $21.10 $17.60 $10.73 $15.60 $2.06 $2.36 $2.87 $45.96 $5.22 $40.93 $48.57 $166.52 $7.15

Sole supply brand (Supplier) Arrow-Azithromycin (Arrow) Chlorsig (Sigma) Nausicalm (AFT) Siterone (Rex Medical) NZ Medical and Scientific (NZ Medical and Scientific) Felo 5 ER (Mylan) Felo 10 ER (Mylan) Arrow-Lisinpril (Arrow) Arrow-Lisinpril (Arrow) Arrow-Lisinpril (Arrow) Pentasa (Pharmaco) Methoblastin (Pfizer) Methoblastin (Pfizer) Medrol (Pfizer) Medrol (Pfizer) Noriday 28 (Pfizer)

A278268 - qA12214

1 of 6

---

Chemical Name Prednisolone sodium phosphate Roxithromycin Roxithromycin Salbutamol

Presentation; Pack size and type Oral liq 5 mg per ml; 30 ml OP, bottle Tab 150 mg; 50 tablets, blister Tab 300 mg, 50 tablets, blister

Current Subsidy $9.95 $9.50 $18.00 $3.70 $3.85 $5.30 $16.06 $27.50 $10.50 $10.55

New tender subsidy $9.95 $8.98 $16.48 $3.52 $3.70 $4.29 $16.06 $27.50 $10.50 $10.55

Sole supply brand (Supplier) Redipred (Aspen Pharmacare) Arrow-Roxythromycin (Arrow) Arrow-Roxythromycin (Arrow) Asthalin (Rex Medical) Asthalin (Rex Medical) Duolin (Rex Medical) Apo-Selegiline (Apotex) Mylan (Mylan) Mylan (Mylan) Apo-Timol (Apotex)

Nebuliser soln, 1 mg per ml, 2.5 ml; 20 nebulisers, ampoule Nebuliser soln, 2 mg per ml, 2.5 ml; 20 Salbutamol nebulisers, ampoule Nebuliser soln, 2.5 mg with ipratropium Salbutamol with bromide 0.5 mg per vial, 2.5 ml; 20 nebulisers, ipratropium bromide ampoule Selegiline hydrochloride Sotalol Sotalol Timolol maleate Tab 5 mg; 100 tablets, bottle Tab 80 mg; 500 tablets, bottle Tab 160 mg; 100 tablets, bottle Tab 10 mg; 100 tablets, bottle

2. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 July 2009, reference pricing of non-tender winning brand will occur on 1 September 2009 and Sole Subsidised Supply commences on 1 December 2009.

The decisions were as follows:

Chemical Name Fluorometholone

Presentation; Pack size and type Eye drops; 5 ml OP, bottle

Current subsidy $4.30

New tender subsidy $4.05

Sole supply brand (Supplier) FML (Allergan)

Brands affected by reference pricing and delisting Flucon (Alcon)

3. Tenders awarded to new pharmaceuticals where no previous listing exists – subsidy begins on 1 July 2009 and Sole Subsidised Supply commences on 1 October 2009.

The decisions were as follows:

Chemical Name Cyproterone acetate

Presentation; Pack size and type Tab 100 mg; 50 tablets, blister

New tender subsidy $41.50

Sole supply brand (Supplier) Siterone (Rex Medical)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 4. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes (where applicable) for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 July 2009; DV Limits and DV Pharmaceuticals will apply from 1 September 2009.

The decisions were as follows:

Chemical Name Alprostadil Amphotericin B

Presentation; Pack size and type Inj 0.5 mg per ml, 1 ml; 5 injections, ampoule Liposomal inj 50 mg; 10 injections, vial

Hospital Supply Brand (Supplier)

Pack Price

DV Limit

DV Pharmaceuticals Brand Name (Supplier) (B) (B)

Prostin VR (Pfizer) $1,417.50 1% AmBisome (Gilead $3,450.00 1%

A278268 - qA12214

Page 2 of 6

---

Chemical Name

Presentation; Pack size and type

Hospital Supply Brand (Supplier) Science)

Pack Price

DV Limit

DV Pharmaceuticals Brand Name (Supplier)

Azithromycin Bupivacaine hydrochloride Bupivacaine hydrochloride Bupivacaine hydrochloride Bupivacaine hydrochloride Cyclizine hydrochloride Cyclosporin Cyproterone acetate Felodipine Felodipine Lignocaine hydrochloride Lignocaine hydrochloride Lignocaine hydrochloride Lignocaine hydrochloride Lignocaine hydrochloride Lignocaine hydrochloride Methotrexate Methotrexate Methylprednisolone Methylprednisolone Prednisolone sodium phosphate Roxithromycin Roxithromycin Salbutamol Salbutamol

Tab 500 mg; 2 tab, blister Inj 0.25%, 20 ml; 5 injections; ampoule Inj 0.5%, 10 ml; 50 injections; ampoule Inj 0.5%, 10 ml theatre pack; 5 injections; ampoule inj 0.5%, 20 ml theatre pack; 5 injections; ampoule Tab 50 mg; 10 tablets, blister Inf 50 mg per ml, 5 ml; 10 injections, ampoule Tab 50 mg; 50 tablets, blister Tab long-acting 5 mg; 90 tablets, blister Tab long-acting 10 mg; 90 tablets, blister Inj 1%, 2 ml; 50 injections, polyamp Inj 1%, 5 ml; 50 injections, polyamp Inj 1%, 20 ml; 5 injections, polyamp Inj 2%, 2 ml; 50 injections, polyamp Inj 2%, 5 ml; 50 injections, polyamp Inj 2%, 20 ml; 5 injections, polyamp Tab 2.5 mg; 30 tablets, bottle Tab 10 mg; 50 tablets, bottle Tab 4 mg; 100 tablets, bottle Tab 100 mg; 20 tablets, bottle Oral liq 5 mg per ml; 30 ml, bottle Tab 150 mg; 50 tablets, blister Tab 300 mg, 50 tablets, blister Nebuliser soln, 1 mg per ml, 2.5 ml; 20 nebulisers, ampoule Nebuliser soln, 2 mg per ml, 2.5 ml; 20 nebulisers, ampoule Tab 80 mg; 500 tablets, bottle

Arrow-Azithromycin (Arrow) Marcain (AstraZeneca) Marcain (AstraZeneca) Marcain (AstraZeneca) Marcain (AstraZeneca) Nausicalm (AFT) Sandimmun (Novartis) Siterone (Rex Medical) Felo 5 ER (Mylan) Felo 10 ER (Mylan) Xylocaine (AstraZeneca) Xylocaine (AstraZeneca) Xylocaine (AstraZeneca) Xylocaine (AstraZeneca) Xylocaine (AstraZeneca) Xylocaine (AstraZeneca) Methoblastin (Pfizer) Methoblastin (Pfizer) Medrol (Pfizer) Medrol (Pfizer) Redipred (Aspen Pharmacare) Arrow-Roxythromycin (Arrow)

$5.95 $35.00 $35.00 $28.00 $25.00 $1.59 $276.30 $21.10 $10.73 $15.60 $57.60 $35.00 $20.00 $62.40 $23.00 $15.00 $5.22 $40.93 $48.57 $166.52 $9.95 $8.98

1% 1% 1% 1% 1% 1% 1% 1%

Zithromax (Pfizer) (B) (B) (B) (B) Marzine (Pfizer) (B) Procur (Douglas)

1% Plendil ER (AstraZeneca) 1% Plendil ER (AstraZeneca) 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% (B) (B) (B) (B) MIN-I-JET(CSL) Lignocaine Delta West (Pharmacia) Hospira (Hospira) Emthexate (WM Bamford) Hospira (Hospira) (B) (B) (B) Romicin (Mylan) Rulide (Sanofi-Aventis) Romicin (Mylan) Rulide (Sanofi-Aventis) (B) (B) Apo-Sotalol (Apotex)

Arrow-Roxythromycin $16.48 (Arrow) Asthalin (Rex Medical) Asthalin (Rex Medical) Mylan (Mylan) $3.52 $3.70

Sotalol

$27.50

1%

Sotacor (BMS) Sotahexal (Novartis)

A278268 - qA12214

Page 3 of 6

---

Chemical Name

Presentation; Pack size and type

Hospital Supply Brand (Supplier)

Pack Price

DV Limit

DV Pharmaceuticals Brand Name (Supplier) Apo-Sotalol (Apotex) Sotacor (BMS) Sotahexal (Novartis)

Sotalol

Tab 160 mg; 100 tablets, bottle

Mylan (Mylan)

$10.50

1%

Tranexamic acid

Inj 100 mg per ml, 5 ml; 10 injections, Cyklokapron (Pfizer) $124.73 ampoule

1%

(B)

5. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 July 2009; DV Limits and DV pharmaceuticals will apply from 1 September 2009; de-listing of other brands in Section H will occur on 1 September 2009.

Presentation; Pack size and type Inj 10 mg per ml, 2.5 ml; 5 injections, ampoule Inj 10 mg per ml, 5 ml; 5 injections, ampoule Inj 10 mg per ml, 1 ml; 1 injection, vial Hospital Supply Brand (Supplier) Tracrium (GSK) Tracrium (GSK) Navelbine (NZ Medical and Scientific) Navelbine (NZ Medical and Scientific) Pack Price $12.55 $26.04 $24.00 DV Limit 1% 1% 1% DV Pharmaceuticals Brand Name (Supplier) Hospira (Hospira) Hospira (Hospira) Vinorelbine Ebewe (InterPharma) Hospira (Hospira) $120.00 1% Vinorelbine Ebewe (InterPharma)

Chemical Name Atracurium besylate Atracurium besylate Vinorelbine **

Vinorelbine **

Inj 10 mg per ml, 5 ml; 1 injection, vial

Hospira (Hospira) **Note Navelbine will also be listed in Section B of the Pharmaceutical Schedule for PCT and ECP preparations accordingly

6. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 July 2009 and DV Limits and DV Pharmaceuticals will apply from 1 September 2009.

The decisions were as follows:

Chemical Name Chloramphenicol Cyproterone acetate Fluorometholone Lisinopril Lisinopril Lisinopril Mesalazine Salbutamol with ipratropium bromide

Presentation; Pack size and type Eye oint 1%; 4 g, bottle Tab 100 mg; 50 tablets, blister Eye drops; 5 ml, bottle Tab 5 mg; 30 tablets, blister Tab 10 mg; 30 tablets, blister Tab 20 mg; 30 tablets, blister Enema 1 g per 100 ml; 7 enemas, bottle Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml; 20 nebulisers, ampoule

Hospital Supply Brand (Supplier) Chlorsig (Sigma) Siterone (Rex Medical) FML (Allergan) Arrow-Lisinpril (Arrow) Arrow-Lisinpril (Arrow) Arrow-Lisinpril (Arrow) Pentasa (Pharmaco) Duolin (Rex Medical)

Pack Price $2.37 $41.50 $4.05 $2.06 $2.36 $2.87 $45.96 $4.29

DV Limit 1% 1% 1% 1% 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) Procur (Douglas) Flucon (Alcon) Apo-Lisinopril (Apotex) Lisopress (Mylan) Apo-Lisinopril (Apotex) Lisopress (Mylan) Apo-Lisinopril (Apotex) Lisopress (Mylan) Asacol (Baxter) (B)

A278268 - qA12214

Page 4 of 6

---

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 23 December 2008.

The decisions were as follows:

Chemical Name Abacavir Sulphate Abacavir Sulphate Abacavir sulphate with lamivudine Amiodarone Hydrochloride Ascorbic Acid Ascorbic Acid Ascorbic Acid Ascorbic Acid Ascorbic Acid Aspirin Azithromycin Bimatoprost Bupivacaine Hydrochloride Bupivacaine Hydrochloride with Adrenaline Bupivacaine Hydrochloride with Adrenaline Bupivacaine Hydrochloride with Adrenaline Cephradine Ciclopiroxolamine Ciclopiroxolamine Cyclizine Lactate Dorzolamide Hydrochloride Dorzolamide Hydrochloride with Timolol Maleate Flecainide Acetate Flecainide Acetate Flecainide Acetate Flecainide Acetate Flecainide Acetate Furosemide Hydrochlorothiazide Hydrochlorothiazide Lamivudine Lamivudine Lamivudine Lamivudine Oxycodone Hydrochloride Oxycodone Hydrochloride Oxycodone Hydrochloride Oxycodone Hydrochloride Oxycodone Hydrochloride Oxycodone Hydrochloride Oxycodone Hydrochloride Oxycodone Hydrochloride

Line Item Oral liq 20 mg per ml Tab 300 mg Tab 600 mg with lamivudine 300 mg Inj 50 mg per ml, 3 ml Eye drops 10% Inj 500 mg per 5 ml Tab 50 mg Tab 100 mg Tab 250 mg Tab EC 300 mg Cap 250 mg Eye Drops 0.03% Inj 0.5%, 20 ml Inj 0.25% with 1:400,000 of adrenaline, 20 ml Inj 0.5% with 1:200,000 of adrenaline, 10 ml Inj 0.5% with 1:200,000 of adrenaline, 10 ml theatre pack Liq 250 mg per 5 ml Crm 1% Soln 1% Inj 50 mg per ml, 1 ml Eye drops 2% Eye drops 2% with timolol maleate 0.5 % Cap long-acting 100 mg Cap long-acting 200 mg Inj 10 mg per ml, 15 ml Tab 50 mg Tab 100 mg Tab 500 mg Tab 12.5 mg Tab 25 mg Oral liq 5 mg per ml Oral liq 10 mg per ml Tab 100 mg Tab 150 mg Cap 2.5 mg Cap 5 mg Cap 10 mg Cap 20 mg Tab controlled-release 5 mg Tab controlled-release 10 mg Tab controlled-release 20 mg Tab controlled-release 40 mg

A278268 - qA12214

Page 5 of 6

---

Chemical Name Oxycodone Hydrochloride Sodium Cromoglycate Sotalol Sotalol Thalidomide Triamcinolone acetonide with gramicidin, neomycin and nystatin Urokinase Urokinase Urokinase Zidovudine (AZT) with Lamivudine

Line Item Tab controlled-release 80 mg Eye drops 2% Inj 10 mg per ml, 4 ml Oral liq Cap 50 mg Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 mcg per g Inj 10,000 iu Inj 100,000 iu Inj 500,000 iu Tab 300 mg with lamivudine 150 mg

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A278268 - qA12214

Page 6 of 6